Lung Cancer Home > Cancer Drug Iressa

If you have been diagnosed with non-small cell lung cancer, you may receive a chemotherapy drug called Iressa® (gefitinib). Specifically, this product is reserved for use in people who are already taking it and are benefiting from it, or people who have benefited from Iressa treatment in the past.
Iressa is a type of tyrosine kinase inhibitor and works by preventing cells from forming correctly, which interferes with how the cells grow and multiply. Research on this drug has shown that Iressa generally does not help people with small-cell lung cancer to live longer; therefore, the manufacturer of the drug no longer manufactures Iressa for use in the United States.
(To learn more about this anticancer drug, click Iressa. This full-length article takes a closer look at what Iressa is used for, dosing information, and potential side effects.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.